Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. A. Mariñas-Pardo, I. Mirones-Aguilar, O. Amor-Carro, R. Fraga-Iriso, B. Lema-Costa, I. Cubillo-Moreno, M. A. Rodríguez-Milla, J. García-Castro, D. Ramos-Barbón (A Coruña, Madrid, Barcelona, Spain). Mesenchymal stem cells down-regulate inflammation but not airway hyperresponsiveness in experimental asthma. Eur Respir J 2011; 38: Suppl. 55, 3269

Member's Comments

No comment yet.

Related content which might interest you: Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 The development of an airway hyperresponsiveness (AHR) depends on mast cells following sensitization without adjuvant Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis Year: 2006 Allergic early phase reactions are caused by mast cells and modulate airway hyperresponsiveness Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 Interaction between epithelial cells and sub-epithelial mesenchymal cells in severe non-allergic asthma Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma Year: 2019 Increased arginase activity contributes to airway remodelling in chronic allergic asthma Source: Eur Respir J 2011; 38: 318-328 Year: 2011 Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis Source: Eur Respir J 2012; 39: 1361-1367 Year: 2012 IL-25 secreted from epithelial cells has the potential to promote airway remodeling in asthma Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Mast cell generated cyclooxygenase products protect from airway hyperresponsiveness in a model of chronic asthma Source: Annual Congress 2011 - Understanding disease and drug mechanisms Year: 2011 Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 PP114 – Mesenchymal stromal cells reduce house dust mite induced allergic airway inflammation in a humanised MIF expressing mouse model Source: ERS Lung Science Conference 2021 Year: 2021 Dendritic cells-nerve interaction in allergic airway inflammation Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma Year: 2012 TNF-α negatively modulates allergen-induced airway hyperresponsiveness through γδ T cells Source: Eur Respir J 2002; 20: Suppl. 38, 27s Year: 2002 Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells Source: Eur Respir J 2012; 39: 439-445 Year: 2012 ILC2s in allergic airway inflammation Source: International Congress 2014 – Highlights from the Lung Science Conference 2014 Year: 2014 Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Thymic stromal lymphopoietin, but not ezrin, could be an early biomarker of airway epithelial dysfunction in acute allergic asthma Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Estrogen prevents airway hyperresponsiveness in a murine model of allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 433s Year: 2006 Increased numbers of alveolar mast cells with an altered phenotype are linked to peripheral airway remodelling in patients with allergic asthma Source: Annual Congress 2012 - Mechanisms of asthma Year: 2012